About the Authors

Genevieve M. Weir

gweir@imvaccine.com

Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Mohan Karkada

Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

David Hoskin

Affiliations Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

Marianne M. Stanford

Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Lisa MacDonald

Affiliation Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada

Marc Mansour

Affiliation Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada

Robert S. Liwski

Affiliations Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology and Laboratory Medicine, Division of Hematopathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

Competing Interests

The authors have read the journal's policy and the authors of this manuscript have the following competing interests: GW, MK, MS, LM, MM were employees of Immunovaccine at the time this study was conducted. GW, LM, MM and RL are named inventors on a pending patent filed using the data of this study. There are no other competing interests to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: GMW MK MM RSL. Data curation: GMW. Formal analysis: GMW. Funding acquisition: MM RSL DH. Investigation: GMW LM. Methodology: GMW MK DH MMS LM MM RSL. Project administration: GMW MK RSL. Resources: GMW LM MM RSL. Supervision: MK MMS MM RSL. Validation: GMW RSL. Visualization: GMW MK DH MS LM MM RSL. Writing – original draft: GMW. Writing – review & editing: MK MMS RSL.